Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cardinal Health

After earnings fell by $300 million, Cardinal Health’s CEO went ‘ruthless’ to turn it around—and he says workers backed him because ‘people want to win’

Jason Hollar, the Gen X boss of the $38 billion Fortune 500 healthcare giant, overhauled the business—and he says employees were also over being "frustrated that we weren't succeeding."

Fortune

Stock Market's Twists And Turns Put Investors In Place To Profit

Mutual fund investors got thrills from the stock market in the second quarter. The S&P 500 stormed back to new highs.

Investors Business Daily

3 Overlooked Dividend Aristocrats To Buy in 2025

These three dividend companies all share one common trait: strong earnings growth and rising cash flow.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Under-The-Radar Dividend Aristocrats Set to Breakout in Q3

These three dividend companies all share one commonality: near-perfect buy ratings and breakout potential.

Barchart

3 Dirt-Cheap Dividend Aristocrats About to Explode Higher

These buy-rated Dividend Aristocrats are trading at rare discounts, offering strong yields, bullish ratings, and potential long-term upside.

Barchart

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

Discover 3 Dividend Aristocrats with high earnings growth, low payout ratios, and strong analyst ratings: perfect for long-term income investors.

Barchart

Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt

While the market has rallied off its April lows, uncertainty continues to dominate investor sentiment. To avoid the volatility, consider these three stocks.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Aristocrats Quietly Dominating The Market in 2025

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

Barchart

Cardinal Health Stock Outlook: Is Wall Street Bullish or Bearish?

Cardinal Health has delivered robust gains over the past year, outperforming the broader market, and analysts are highly bullish on its outlook.

Barchart

Earnings Just Sent This Healthcare Stock to New Record Highs

Cardinal Health (CAH) rallied to a new record high on Thursday and closed the day 3% higher. Cardinal Health rallied after its release of positive fiscal Q3 earnings results and a hike in guidance for the full year. The company remains in a long-term 3-year uptrend. Company Description: Cardinal Health...

Barchart

What You Need To Know Ahead of Cardinal Health's Earnings Release

Cardinal Health is scheduled to announce its third-quarter results next month, with analysts anticipating a single-digit earnings growth.

Barchart

Cardinal Health Has a String of New Highs

Summary Cardinal Health (CAH) shows strong technical buy signals, with a 3.95% gain since the Trend Seeker buy signal on 3/18 and consistent price appreciation. The company operates globally, providing a wide range of healthcare services and products, including pharmaceuticals, medical supplies, and radiopharmaceuticals. Barchart's technical indicators highlight CAH's positive...

Barchart

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health has surpassed the broader healthcare sector’s performance over the past year, and analysts are expressing continued confidence in its growth potential.

Barchart

Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink?

Cardinal Health has observed a notable surge in stock prices recently and received several ratings upgrades shifting the consensus to a "Strong Buy."

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

What to Expect From Cardinal Health's Next Quarterly Earnings Report

Cardinal Health is expected to release its fiscal 2025 second-quarter earnings this month, and analysts project a single-digit profit decline.

Investors Business Daily

Cardinal Health Sees Relative Strength Rating Climb To 74

Cardinal Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

Is Cardinal Health Stock Underperforming the Dow?

Cardinal Health has underperformed the Dow Jones Industrial Average over the past year, yet analysts remain optimistic about the stock’s prospects.

Investors Business Daily

Stocks With Rising Relative Strength: Cardinal Health

Cardinal Health shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Wall Street Bullish or Bearish on Cardinal Health Stock?

Although Cardinal Health has underperformed relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Investors Business Daily

Cardinal Health Stock Sees IBD RS Rating Improve To 71

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Barchart

What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

Barchart

Is Cardinal Health Stock Underperforming the Nasdaq?

Despite Cardinal Health’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Investors Business Daily

Cardinal Health Stock Sees Relative Strength Rating Climb To 71

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Investors Business Daily

Cardinal Health Clears Buy Point On Bullish Fiscal 2025 View

Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations

Barchart

Stock Index Futures Tread Water as Key U.S. Inflation Data Looms

September S&P 500 E-Mini futures (ESU24) are up +0.02%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.09% this morning as market participants held back from making any big bets ahead of the release of the U.S. consumer inflation report.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Chipotle Mexican Grill

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.